M&A

Astrazeneca shows megamergers were still possible in 2020
EP Vantage
Wed, 01/6/21 - 10:41 am
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Bayer
Asklepios
Merck
VelosBio
Gilead Sciences
Forty Seven
Immunomedics
JNJ
Momenta
AbbVie dumps unwanted Sosei neuro pact from Allergan's past
Fierce Biotech
Tue, 01/5/21 - 10:17 am
AbbVie
Allergan
M&A
Sosei
The top medtech deals of 2020 (and one that got away)
Medtech Dive
Tue, 01/5/21 - 10:16 am
devices
Medtech
M&A
Teladoc
Livongo Health
Stryker
Wright Medical
Medtronic
EXACT Sciences
Philips
BioTelemetry
Illumina
Grail
Siemens
Varian
In quick start to new year's M&A, Arvelle Therapeutics hands reins to Angelini as it nears EU approval for cenobamate
Endpoints
Mon, 01/4/21 - 10:41 am
Arvelle Therapeutics
Angelini Pharma
M&A
CNS
epilepsy
cenobamate
Axovant
Charles River bags antibody discovery-focused Distribution Bio for $104M, signaling return to pre-pandemic buyout spree
Endpoints
Mon, 01/4/21 - 10:38 am
Charles River Labs
CROs
M&A
Distribution Bio
Hologic Kicks off 2021 with Some M&A Action
Medical Devices and Diagnostics Industry
Mon, 01/4/21 - 10:31 am
devices
M&A
Hologic
Somatex
biopsy site markers
breast health
10 Biopharma Stories to Look Forward to in 2021
BioSpace
Sun, 01/3/21 - 04:39 pm
pandemic
COVID-19
vaccines
Joe Biden
drug pricing
M&A
venture capital
JNJ
Biomarin
Bluebird Bio
TG Therapeutics
Biogen
AstraZeneca
Eli Lilly to buy New York drugmaker for up to $1B
Beckers Hospital Review
Thu, 12/31/20 - 11:59 am
Eli Lilly
Prevail Therapeutics
M&A
neurodegenerative disease
Olympus acquires Veran Medical Technologies
Mass Device
Wed, 12/30/20 - 10:45 am
Olympus
Veran Medical Technologies
devices
M&A
Pulmonology
Vertex teams up with Skyhawk, leaning on another biotech in bid to diversify
BioPharma Dive
Tue, 12/22/20 - 11:29 pm
Vertex Pharmaceuticals
Skyhawk Therapeutics
small molecule drugs
M&A
Agios, changing its identity, to sell cancer drug business to Servier
BioPharma Dive
Mon, 12/21/20 - 11:11 am
Agios Pharmaceuticals
cancer
M&A
Servier
The top 5 pharma M&A deals of 2020
Pharmaforum
Mon, 12/21/20 - 11:07 am
M&A
AstraZeneca
Alexion
Gilead Sciences
Immunomedics
Forty Seven
JNJ
Momenta
Sanofi
Principia Biopharma
[video+transcript]Is AstraZeneca Paying Too Much for Alexion?
Motley Fool
Mon, 12/21/20 - 11:00 am
M&A
AstraZeneca
Alexion
Biggest Medtech Losses in 2020
Medical Devices and Diagnostics Industry
Sun, 12/20/20 - 10:59 pm
devices
Medtech
hospitals
Orthopedic
elective surgery
M&A
Philips spends nearly $3bn to integrate Biotelemetry
EP Vantage
Fri, 12/18/20 - 10:49 am
Philips
BioTelemetry
M&A
devices
Novartis acquires a small biotech and its trio of brain drugs
BioPharma Dive
Thu, 12/17/20 - 11:57 am
Novartis
M&A
Cadent
Neuroscience
Seneca Biopharma merges with Leading BioSciences, becoming Palisade Bio
Fierce Biotech
Thu, 12/17/20 - 11:09 am
Seneca Biopharma
Leading BioSciences
Palisade Bio
NASDAQ
M&A
Pharmacquired: What a surprise deal does for AstraZeneca and Alexion
BioPharma Dive
Wed, 12/16/20 - 11:31 am
AstraZeneca
Alexion
M&A
Rare Diseases
Lilly to acquire gene therapy specialist, Prevail Therapeutics, in a deal worth US$1.04bn
Biopharma Reporter
Tue, 12/15/20 - 10:57 am
Eli Lilly
Prevail Therapeutics
M&A
AstraZeneca to buy Alexion for $39B
BioPharma Dive
Sat, 12/12/20 - 02:30 pm
AstraZeneca
Alexion
M&A
Rare Diseases

Pages